• Explore /
  • Poster
  • / Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.

Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.

Abstract Poster

Authors

null

Anthony J. Chalmers

University of Glasgow, Glasgow, United Kingdom

Anthony J. Chalmers , Susan Short , Colin Watts , Christopher Herbert , Anna Morris , Jamie Stobo , Garth Cruickshank , Sara Erridge , Lisa Godfrey , Sarah Jefferies , Juanita Suzanne Lopez , Catherine McBain , Marc Pittman , Susan Dillon , Allan James , Stefan A Nowicki , Aiofe Williamson , Caroline Kelly , Sarah E. R. Halford , Laurence Dunn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT01390571

Citation

J Clin Oncol 36, 2018 (suppl; abstr 2018)

DOI

10.1200/JCO.2018.36.15_suppl.2018

Abstract #

2018

Poster Bd #

176

Abstract Disclosures

Similar Posters

First Author: Lawrence Kleinberg

First Author: Dinu Stefan

First Author: Jiayi Huang

First Author: Frank Saran